chr10-81875426-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010848.4(NRG3):c.86C>A(p.Ala29Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000364 in 1,098,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010848.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NRG3 | NM_001010848.4 | c.86C>A | p.Ala29Glu | missense_variant | 1/9 | ENST00000372141.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NRG3 | ENST00000372141.7 | c.86C>A | p.Ala29Glu | missense_variant | 1/9 | 1 | NM_001010848.4 | A2 | |
NRG3 | ENST00000404547.5 | c.86C>A | p.Ala29Glu | missense_variant | 1/10 | 1 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000137 AC: 2AN: 146200Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000210 AC: 2AN: 952572Hom.: 0 Cov.: 30 AF XY: 0.00000447 AC XY: 2AN XY: 447838
GnomAD4 genome AF: 0.0000137 AC: 2AN: 146200Hom.: 0 Cov.: 31 AF XY: 0.0000141 AC XY: 1AN XY: 71120
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.86C>A (p.A29E) alteration is located in exon 1 (coding exon 1) of the NRG3 gene. This alteration results from a C to A substitution at nucleotide position 86, causing the alanine (A) at amino acid position 29 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at